Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure

Heart failure (HF) is associated to endothelial dysfunction that promotes the increase of arterial stiffness thus augmenting myocardial damage. Sacubitril/Valsartan is used in the treatment of HF reduced ejection fraction (HFrEF) and has been proven effective in reducing cardiovascular disease (CVD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassano, Velia, Armentaro, Giuseppe, Magurno, Marcello, Aiello, Vincenzo, Borrello, Francesco, Miceli, Sofia, Maio, Raffaele, Perticone, Maria, Marra, Alberto M., Cittadini, Antonio, Hribal, Marta L., Andreozzi, Francesco, Sesti, Giorgio, Sciacqua, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760824/
https://www.ncbi.nlm.nih.gov/pubmed/36545306
http://dx.doi.org/10.3389/fphar.2022.1069828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760824/
https://www.ncbi.nlm.nih.gov/pubmed/36545306
http://dx.doi.org/10.3389/fphar.2022.1069828

Ejemplares similares